ID

33897

Description

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01661790

Link

https://clinicaltrials.gov/show/NCT01661790

Keywords

Versions (1)
  1. 1/6/19 1/6/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 6, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Malignant Pleural Effusion NCT01661790

English

Eligibility Malignant Pleural Effusion NCT01661790

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with advanced recurrent or progressive nsclc proven cytohistologically
Description

Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent | Non-Small Cell Lung Carcinoma Progressive

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278517
UMLS CUI [3,1]
C0007131
UMLS CUI [3,2]
C0205329
karnofsky performance status (kps) ≥60
Description

Karnofsky Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
life expectancy ≥ 2 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
no history of severe diseases of major organs including liver, heart, and kidney
Description

Absence Disease Organ Major | Absence Liver diseases Severe | Absence Heart Diseases Severe | Absence Kidney Diseases Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C0178784
UMLS CUI [1,4]
C0205164
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0023895
UMLS CUI [2,3]
C0205082
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0018799
UMLS CUI [3,3]
C0205082
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0022658
UMLS CUI [4,3]
C0205082
no previous intrapleural therapy
Description

Absence Therapy Intrapleural

Data type

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C3282906
written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
active thoracic cavity or systemic bleeding
Description

Thoracic cavity Hemorrhage | Hemorrhage Systemic

Data type

boolean

Alias
UMLS CUI [1,1]
C0230139
UMLS CUI [1,2]
C0019080
UMLS CUI [2,1]
C0019080
UMLS CUI [2,2]
C0205373
active pleural or systemic infection.
Description

Pleural infection | Sepsis

Data type

boolean

Alias
UMLS CUI [1]
C0919907
UMLS CUI [2]
C0243026
known sensitivity to bevacizumab or cisplatin
Description

Hypersensitivity Bevacizumab | Cisplatin allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0796392
UMLS CUI [2]
C0570702
refusal to participate in the study.
Description

Refusal to Participate Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C1136454
UMLS CUI [1,2]
C0008976
Back to the top of the page

Similar models

Eligibility Malignant Pleural Effusion NCT01661790

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent | Non-Small Cell Lung Carcinoma Progressive
Item
patients with advanced recurrent or progressive nsclc proven cytohistologically
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278517 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
Karnofsky Performance Status
Item
karnofsky performance status (kps) ≥60
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥ 2 months
boolean
C0023671 (UMLS CUI [1])
Absence Disease Organ Major | Absence Liver diseases Severe | Absence Heart Diseases Severe | Absence Kidney Diseases Severe
Item
no history of severe diseases of major organs including liver, heart, and kidney
boolean
C0332197 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0023895 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0018799 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0022658 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
Absence Therapy Intrapleural
Item
no previous intrapleural therapy
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3282906 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Thoracic cavity Hemorrhage | Hemorrhage Systemic
Item
active thoracic cavity or systemic bleeding
boolean
C0230139 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
C0019080 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Pleural infection | Sepsis
Item
active pleural or systemic infection.
boolean
C0919907 (UMLS CUI [1])
C0243026 (UMLS CUI [2])
Hypersensitivity Bevacizumab | Cisplatin allergy
Item
known sensitivity to bevacizumab or cisplatin
boolean
C0020517 (UMLS CUI [1,1])
C0796392 (UMLS CUI [1,2])
C0570702 (UMLS CUI [2])
Refusal to Participate Clinical Trial
Item
refusal to participate in the study.
boolean
C1136454 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial